Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A phase III, randomized, multicenter, efficacy and safety study comparing the combination of PEG-IFN alfa-2a (Ro 25-8310) and ribavirin to IFN alfa-2b and ribavirin in the treatment of patients with chronic hepatitis C
peg-interferon alpha-2a
NV15801
chronic hepatitis c
Phase 3
 
January 2014

Powered by ideaPoint, Inc.